News and press
Metadvice CEO, Andrew Rut, Discusses AI in Healthcare for Open Access Government
Our CEO, Andrew Rut, has been featured in the April 2024 edition of Open Access Government, discussing the role AI can play in enhancing healthcare delivery and patient care.
The article is also available to read on the Open Access Government website.
New textbook on Insulin by our Chief Medical Officer, Andrew Krentz
Metadvice was extremely proud to see the publication of a new textbook, Insulin: Deficiency, Excess and Resistance in Human Disease, edited by our Chief Medical Officer, Andrew Krentz.
It was just over a century ago that insulin was discovered, and its lifesaving introduction to clinical practice was marked one of the most celebrated accomplishments of medical science.
The book offers a comprehensive guide to current and future therapeutic options via a focus on insulin deficiency and insulin resistance in human disease. Given that best clinical practice is based on a clear understanding of insulin pathophysiology (and how this leads to the disease states of type 1 diabetes, obesity-associated type 2 diabetes, cardiometabolic disease, cancer, and other relevant disorders) the timing of this publication is prescient.
Professor Krentz notes, “Living with type 1 diabetes remains exceedingly challenging for patients and families. Over the past century, type 2 diabetes has become a major cause of morbidity and premature mortality worldwide. Many aspects of care remain suboptimal, which means advances in precision medicine require clinicians and scientists to maintain their awareness across the spectrum of diseases.”
With four decades of clinical and translational research experience in metabolic, endocrine and related cardiovascular disorders, Andrew brings invaluable expertise to the Metadvice team. We wish him many congratulations on this new publication.
Metadvice’s CEO, Andrew Rut, is interviewed on BBC World News
In March 2024, our CEO, Andrew Rut, was interviewed for the BBC World News programme, World Business Report, by presenter Sally Bundock.
Andrew shared his insights about our work to optimise patient treatment and thus relieve the burden on healthcare systems across the globe. As he pointed out, “Most patients today with long term health issues suffer from more than one condition – AI and our software enable doctors to confidently manage the totality of a patient in a holistic way.”
Digital technologies are central to addressing the growing burden on global healthcare systems. We are at the forefront of using AI to redefine medical practice and reshape healthcare, enabling clinical teams to deliver targeted, evidence-based, and individualised treatments. Our mission is simple: to enable everyone to live healthier lives for longer.
Watch the full interview via LinkedIn.
How is AI transforming the pharma landscape? Metadvice CEO, Andrew Rut, on the Spencer Group Podcast
AI is not only fundamental to the design and execution of successful clinical trials, but also to ensuring patients receive the medicines they require.
In this podcast with Spencer Group CEO, Julian Minett, and Cisiv Ltd Chairman, Steve Powell, our CEO, Andrew Rut, discusses the impact of AI on the pharmaceutical landscape, and how it is addressing complex challenges posed by overlapping chronic diseases.
As Andrew shares, enhanced clinical decision making is critical to driving better health outcomes for patients – particularly those with complex comorbidities. By providing clinicians with tools that leverage the latest guidelines, along with refinements based on ‘digital twins’, we enable better, more transparent patient management.
Listen to the full episode above, or via the Spencer Group website.